Nanodelivery Systems for Topical Management of Skin Disorders

Mol Pharm. 2021 Feb 1;18(2):491-505. doi: 10.1021/acs.molpharmaceut.0c00154. Epub 2020 Jun 14.

Abstract

Topical drug delivery has inherent advantages over other administration routes. However, the existence of stratum corneum limits the diffusion to small and lipophilic drugs. Fortunately, the advancement of nanotechnology brings along opportunities to address this challenge. Taking the unique features in size and surface chemistry, nanocarriers such as liposomes, polymeric nanoparticles, gold nanoparticles, and framework nucleic acids have been used to bring drugs across the skin barrier to epidermis and dermis layers. This article reviews the development of these formulations and focuses on their applications in the treatment of skin disorders such as acne, skin inflammation, skin infection, and wound healing. Existing hurdles and further developments are also discussed.

Keywords: nanomedicine; nanoparticles; skin disorder; topical drug delivery.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Administration, Cutaneous
  • Animals
  • Dermatologic Agents / administration & dosage*
  • Dermatologic Agents / pharmacokinetics
  • Disease Models, Animal
  • Drug Carriers / chemistry*
  • Drug Compounding
  • Drug Liberation
  • Gold / chemistry
  • Humans
  • Nanoparticles / chemistry*
  • Nucleic Acids / chemistry
  • Polymers / chemistry
  • Silicon Dioxide / chemistry
  • Skin / metabolism
  • Skin Diseases / drug therapy*

Substances

  • Dermatologic Agents
  • Drug Carriers
  • Nucleic Acids
  • Polymers
  • Gold
  • Silicon Dioxide